Emami Ltd. is one of India’s leading and fastest-growing personal and healthcare businesses. Its portfolio includes household brands, such as BoroPlus, Fair and Handsome, Mentho Plus Balm, Navratna, Kesh King, Fast Relief, and Zandu Balm. It was established in 1974, with its headquarters in Kolkata, West Bengal. During FY 2021-2022, the company’s total revenue was Rs 3,287.28 crore, up 11.40% against Rs 2,950.80 in the previous financial year, 2020-2021. On 21 October 2022, the company’s market capitalisation stood at Rs 21,135 crore.
Emami Ltd.’s share is listed on the Bombay Stock Exchange with the code 531162, and on the National Stock Exchange with the code EMAMILTD.
The company’s product portfolio comprises over 300 products based on ayurvedic formulations. Its operations are spread across 60 countries, including SEA, MENAP, SAARC, Eastern Europe, CIS, and African countries. In 2022, Emami Ltd. acquired Dermicool, one of India’s leading prickly heat and cool talc brands.
The company’s shareholding pattern on 30 September 2022 showed a 54.27% promoter stake, 11.25% FII stake, 27.02% DII stake, and 7.47% public stake. The leading promoter was Suraj Finvest, with a 23.96% share. In the June 2022 quarter, promoters unpledged 3.77% of shares, bringing the total pledge to 33.37% of promoter holdings.
Mr R S Agarwal is the company’s founder and chairman emeritus. The other members of the management team include Mr N H Bhansali, Mr A K Joshi, Mr Vivek Dhir, Mr Gul Raj Bhatia, Ms Punita Kalra, Mr Dhiraj Agarwal, Mr Chandra Kant Katiyar, Mr Tuhin Biswas, and Mr Vinod Rao. Its auditors include S R Batliboi & Co. LLP. As of 30 September 2022, the company’s total number of outstanding shares was 44.12 crores.
On 21 October 2022, the company’s share price closed at Rs 477.15 on BSE, while on NSE, it closed at Rs 479.10. The 52-week high price for Emami Ltd.’s share was Rs 578.50, and the 52-week low price was Rs 393.40. The share’s one-year return was -10.30%, and the six-month return was 0.07%.
As of September 2022, L&T Midcap Fund had a 4.04% stake in the company. DSP Midcap Fund had a 2.98% stake, Mirae Asset Emerging Bluechip Fund had a 2.03% stake, and Kotak Emerging Equity Fund had a 1.33% stake.
Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.
Emami share price as on 17 Jul 2024 is Rs. 773.2. Over the past 6 months, the Emami share price has increased by 41% and in the last one year, it has increased by 81.78%. The 52-week low for Emami share price was Rs. 410 and 52-week high was Rs. 806.05.